Abbott’s Architect hepatitis B surface antigen (HBsAg) diagnostic test has been awarded the CE mark.

The HBsAg quantitative assay helps in the detection of acute and chronic Hepatitis B virus infections, and screens blood and blood products using the Architect immunochemistry system.

Go deeper with GlobalData

Go deeper with GlobalData

The gold standard of business intelligence.

Find out more

Discover B2B Marketing That Performs

Combine business intelligence and editorial excellence to reach engaged professionals across 36 leading media platforms.

Find out more

The test is a chemiluminescent microparticle immunoassay that enables clinicians to identify patients with low levels of HBsAg.

Biomnis biologist Thoai Duong Ly said that the Architect test helps to identify mutant strains of the Hepatitis B virus.

Medical Device Network Excellence Awards - Nominations Closed

Nominations are now closed for the Medical Device Network Excellence Awards. A big thanks to all the organisations that entered – your response has been outstanding, showcasing exceptional innovation, leadership, and impact

Excellence in Action
Awarded for Innovation in Remote Hearing Diagnostics , hearX’s Self Test Kit (STK) delivers clinically validated audiometry via smart devices, enabling remote, scalable hearing assessments in homes, clinics and retail. Learn how hearX is redefining hearing care delivery and reducing costs for providers globally.

Discover the Impact